The rationale for treatment of HIV infection shortly after infection has frequently been considered separately from treatment of chronic HIV infection because of the possibility that the use of antiretroviral therapy (ART) in this setting could preserve anti-HIV immunity mediated by CD4- T-cells and other cells [1–5]. Here, CD4 is linked to HIV infectious disease.